Eduardo Garza

Eduardo Garza
Laboratorio PGM · Director

MD, PhD

About

13
Publications
1,488
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
23
Citations
Introduction
Eduardo Garza currently works at PGM | Laboratorio de Patología Clínica y Genética Molecular. Eduardo does research in Clinical Pathology and Molecular Genetics.
Additional affiliations
September 2011 - October 2014
University of Rome Tor Vergata
Position
  • Research Assistant
Description
  • Thesis: Implementation of high-resolution melting tests for molecular diagnosis in hematological diseases.
March 2011 - January 2018
Independent Researcher
Independent Researcher
Position
  • Head of Department
November 2010 - November 2010
Mayo Clinic - Scottsdale
Position
  • Medical Research Clerkship
Education
April 2015 - July 2018
Tecnológico de Monterrey
Field of study
  • Business and Administration
September 2011 - October 2014
University of Rome Tor Vergata
Field of study
  • PhD Hematology Molecular Lab
March 2008 - February 2011
Universidad Popular Autónoma del Estado de Puebla (UPAEP)
Field of study
  • Laboratory Medicine / Clinical Pathology

Publications

Publications (13)
Preprint
Full-text available
SARS-CoV-2 variants of concern (VOC) have spread throughout the world. In Mexico, VOC B.1.351 has been detected on one occasion and B.1.1.7 several times. We detected lineages B.1.351 and B.1.1.7 in patients who traveled to USA and B.1.1.7 in a patient with no travel history. Article summary line Introduction of B.1.351 and B.1.1.7 S ARS-CoV-2 var...
Article
Full-text available
Chronic lymphocytic leukemia (CLL) is characterized by extremely variable clinical course indicating substantial differences in the biology of the disease. Molecular characterization provides new insights useful for treatment decision making. We report on a patient diagnosed with CLL, whose disease was characterized by episodes of rapid progression...
Article
Full-text available
The aim of this study was to investigate whether the amount of serum antibodies to melanocyte antigens could predict clinical activity or disease progression in patients with vitiligo. A solid-phase enzyme immunoassay was developed to semiquantitate serum antibodies to a human melanocyte extract and was used in 127 patients, 93 of whom showed clini...
Article
Full-text available
Somatic mutations of the spliceosome machinery have been recently identified by whole genome analysis in hematologic diseases, such as myelodysplastic syndrome, chronic lymphocytic leukemia, myeloproliferative neoplasms, acute myeloid leukemia, and advanced forms of mastocytosis, and also in nonhematologic conditions. SRSF2 is a member of the serin...
Article
Full-text available
RESUMEN La nucleofosmina (NPM1) pertenece a la familia de chaperonas de las nucleoplasminas; es una fosfoproteína de expresión ubicua de localización fundamentalmente nucleolar, que se desplaza constantemente del núcleo al citoplasma. Se ha descrito un gran número de proteínas que interaccionan con la nucleofosmina, que juega un papel relevante en...
Article
Full-text available
Fasting serum prolactin (PRL) levels in response to metoclopramide (MCP) and lymphocyte cytokine profiles was studied in patients given allografts and their donors. Thirty normoprolactinemic volunteers (12-59 years) were studied: group 1, 10 healthy men; group 2, 8 males and 2 females with various hematologic diseases; and group 3, 3 males and 7 fe...
Article
Full-text available
RESUMEN Antecedentes: hay muy poca información sobre porfirias hereditarias en México. En la literatura internacional solo hay cuatro trabajos, escritos por autores mexicanos, publicados sobre el tema. Objetivo: analizar la experiencia obtenida en un lapso de 28 años en los Laboratorios Clínicos de Puebla, con los estudios de laboratorio orientados...

Network

Cited By

Projects

Project (1)